SK-Pharmacy

News

Meeting with distributors, logisticians and representatives of foreign manufacturers of drugs and medical products
15 June 2016
Meeting with distributors, logisticians and representatives of foreign manufacturers of drugs and medical products

The Chairman of Board of LLC "SK-pharmacy" Alibaev N. N. held a regular working meeting with the participation of distributors, logisticians and representatives of foreign manufacturers of drugs and medical products, as well as NCEDMP.

During the meeting they discussed a wide range of accumulated topical questions, duringthe discussion of which recommendations were mutually agreedand set objectives for each of the parties.

The main topic of the agenda were the issues of: quality and safety of medicines and medical products of domestic manufacture, processing of claims for products from the healthcare organizations, provision of the terms of delivery of medicines and medical devices in 2016, as well as issues of improvement of normative legal acts in the framework of the implementation of mandatory social health insurance, presentation of Monitoring system for medications.

Voiced issues are constantly on the agenda of the Partnership, as these issues are some of the most urgent and vital, so meeting in this format, with the participation of the specified offices are held not for the first time.Just on the eve was held a meeting with the domestic manufacturers, on which were also raised similar questions and problems.

- Such meetings we plan to conduct regularly, that helps and motivates all participants to keep a high standard in their field. The quality of medications – is our first task, quality of service (logistics, etc.) is another important component, and only with a clear understanding of the goal to which we go, and with constant surveillance there may be some progress in this matter–comments the Chairman of Board of “SK-pharmacy” Alibaev N.N.

Following the results of meeting were assigned tasks among the departments concerned, with the assignment of duties and responsibilities of their supervisors in the Protocol.

A source: Media-service of LLP "SK-Pharmacy"